期刊文献+

膀胱癌转化生长因子β_1过表达的临床意义 被引量:3

Clinical significance of transforming growth factor β_1 in human bladder transitional cell carcinomas
原文传递
导出
摘要 目的 探讨膀胱移行细胞癌TGFβ1蛋白及mRNA异常表达的临床意义。  方法 采用SP法检测 74例膀胱癌组织中TGFβ1蛋白的表达 ;QRT PCR方法检测 43例膀胱癌TGFβ1mRNA转录水平。 结果 膀胱癌TGFβ1蛋白表达阳性率为 89.2 % ,T2 ~T4 浸润性膀胱癌TGFβ1过表达率为 83.8% ,明显高于Ta~T1表浅性膀胱癌 (33.3% ) ,P <0 .0 5 ;复发转移组 30例中TGFβ1过表达 2 9例 ,而无瘤存活组 44例中过表达 30例 ,P <0 .0 0 5 ;膀胱癌组织TGFβ1mRNA含量明显高于正常膀胱组织。 结论 TGFβ1过表达与膀胱癌浸润生长方式和预后等有密切关系 ,可能成为评价膀胱癌预后的有效指标之一。 Objective To investigate the influence of the aberrant protein expression and mRNA transcription of transforming growth factor β 1(TGFβ 1) on the biological behavior of human bladder transitional cell carcinomas. Methods The expression of TGFβ 1 was investigated in 74 specimens of TCCs by SP immunohistochemistry staining, and the level of TGFβ 1 mRNA were determined in 43 cases of TCCs by the method of quantitative RT PCR. Results The positives expression rate of TGFβ 1 was 89.2%. Superficial tumors had lower overexpressive rate of TGFβ 1(33.3%) than the invasive TCCs(83.8%), P <0.05. Significantly higher overexpressive rate of TGFβ 1 was observed in recurrent and metastatic TCCs(29/30) than the tumor free survival TCCs(30/44), P <0.005. The level of TGFβ 1 mRNA expression in TCCs was higher than that detected in normal bladder epithelium, P <0.05. Conclusions The expression of TGFβ 1 in TCCs is higher than in normal bladder tissues. The overexpression of TGFβ 1 is related significantly with the invasive tumors and with the recurrence and the 5 years survival rate of TCCs. Overexpression of TGFβ 1 could be one of the effective prognostic markers for patients with TCCs.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2002年第8期498-500,共3页 Chinese Journal of Urology
关键词 过表达 膀胱肿瘤 转化生长因子Β1 TGFΒ1 Bladder neoplasms Carcinoma,transitional cell Transforming growth factor β 1
  • 相关文献

参考文献3

二级参考文献6

  • 1张祥生,王子明,万恒麟.TGFβ抑制肿瘤细胞生长的作用及在泌尿系肿瘤中的研究现状[J].国外医学(泌尿系统分册),1996,16(1):17-19. 被引量:5
  • 2顾方六 吴阶平.肾肿瘤.泌尿外科学[M].济南:山东科学技术出版社,1993.476-492.
  • 3徐勇,中华泌尿外科杂志,1995年,16卷,534页
  • 4Jiang W G,Eur J Surg Oncol,1994年,20卷,493页
  • 5张祥生,国外医学.泌尿系统分册,1996年,16卷,17页
  • 6顾方六,泌尿外科,1993年,477页

共引文献21

同被引文献17

  • 1卢德宏,董彬,徐庆中.细胞增殖周期的调控及其抗调控因子抗体在肿瘤病理学研究中的应用[J].诊断病理学杂志,1996,3(1):61-62. 被引量:13
  • 2鄂征.组织培养和分子细胞学技术[M]:第1版[M].北京:北京出版社,1999.153-158.
  • 3鄂征 主编.组织培养和分子细胞学技术:第1版[M].北京:北京出版社,1999.153-158.
  • 4Kjellman C, Olofsson SP, Hansson O, et al. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. Int J Cancer,2000,89:251-258.
  • 5Ye SC, Foster JM, Li W, et al. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.Cancer Res, 1999,59:4725-4731.
  • 6Baldwin RL, Tran H, Karian BY. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor β growth arrest independent of transforming growth factor β/Smad signaling.Cancer Res, 2003, 63:1413-1419.
  • 7Akhurst R J, Balmain A. Genetic events and the role of TGF beta in epithelial tumour progression. J Pathol, 1999,187 : 82-90.
  • 8Park BJ, Park JI.Byun DS, et al. Mitogenic conversion of transforming growth factor-betal effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer. Cancer Res, 2000,60: 3031-3038.
  • 9Xiong B, Gong LL, Zhang F, et al. TGF betal expression and angiogenesis in colorectal cancer tissue. World J Gastroenterol, 2002,8:496-498.
  • 10Matthews E, Yang T, Janulis L, et al. Down-regulation of TGF-betal production restores immunogenicity in prostate cancer cells, Br J Cancer,2000,83: 519-525.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部